Implantable loop recorder for continuous beat-to-beat monitoring (REVEAL) versus conventional strategy in the analysis of syncope of unknown aetiology

ISRCTN ISRCTN29754044
DOI https://doi.org/10.1186/ISRCTN29754044
Secondary identifying numbers N/A
Submission date
19/12/2005
Registration date
19/12/2005
Last edited
26/08/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Signs and Symptoms
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr W. Wieling
Scientific

Academic Medical Center
Department of Internal Medicine
Amsterdam
1105 AZ
Netherlands

Phone +31 (0)20 5669111
Email w.wieling@amc.uva.nl

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeDiagnostic
Scientific title
Study objectives1. Compare the diagnostic yield and time to diagnosis of the REVEAL with the diagnostic yield and time to diagnosis of a conventional diagnostic approach
2. Test the hypothesis that REVEAL can improve quality of life
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedSyncope
InterventionImplantable loop recorders.
Conventional strategy includes external loop recording, and (if necessary) repeating of 24 hours holter monitoring, echocardiography or exercise-ECG.
Intervention typeOther
Primary outcome measureDiagnostic yield defined as number of patients with arrhythmias with symptoms + number of patients with sinus rhythm with symptoms divided by the total number of patients undergoing the test.
Secondary outcome measures1. Quality of life
2. Cost-analysis
Overall study start date01/01/2000
Completion date31/07/2003

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants85
Key inclusion criteria1. No diagnosis after history, physical exam and ECG
2. No diagnosis after echocardiography
3. No diagnosis after 24 hours holter monitoring
4. No diagnosis after exercise-testing
5. Age >18 years, <80 years
6. At least one syncopal episode with trauma or 2 witnessed syncopal episodes
7. Informed consent
Key exclusion criteria1. (Cardiac) High risk patients
2. Abnormal electrophysiological examination
3. Pace-maker or intra-cardiac defibrillator
4. Pregnancy
5. Not able to activate implantable loop recorder
6. Serious disease with life expectancy <2 years
Date of first enrolment01/01/2000
Date of final enrolment31/07/2003

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Academic Medical Center
Amsterdam
1105 AZ
Netherlands

Sponsor information

Academic Medical Centre (AMC) (Netherlands)
Hospital/treatment centre

Meibergdreef 9
Amsterdam
1105 AZ
Netherlands

Website http://www.amc.uva.nl
ROR logo "ROR" https://ror.org/03t4gr691

Funders

Funder type

Charity

Dutch Heart Foundation (Netherlands)
Private sector organisation / Trusts, charities, foundations (both public and private)
Alternative name(s)
Heart Foundation
Location
Netherlands
Medtronic BV (Netherlands)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan